| 1 | 1792-17-2 | Dibutylurea | C9H20N2O | 172.273 | 65-75℃ | |
| 2 | 1792-36-5 | 1H-Naphth[2,3-d]imidazole,2-methyl-(7CI,9CI) | C12H10N2 | 182.2212 | | |
| 3 | 1792-40-1 | 2-METHYL-5-NITRO-1H-BENZIMIDAZOLE | C8H7N3O2 | 177.16 | 223-225 °C | |
| 4 | 1792-41-2 | 2,5-DIMETHYL-1H-BENZIMIDAZOLE | C9H10N2 | 146.19 | 202-205 °C | |
| 5 | 1792-42-3 | 1H-NAPHTH[1,2-D]IMIDAZOLE, 2-METHYL- | C12H10N2 | 182.22 | | |
| 6 | 1792-47-8 | tetramethyl 4aH-pyrido[2,1-b][1,3]benzothiazole-1,2,3,4-tetracarboxylate | C19H17NO8S | 419.40518 | | |
| 7 | 1792-72-9 | Piperidine-3,5-diol | C5H11NO2 | 117.15 | | |
| 8 | 1792-73-0 | 1,3-Benzodioxole, hexahydro-, (3aR,7aR)-rel- | C7H12O2 | 128.17 | | |
| 9 | 1792-81-0 | cis-1,2-Cyclohexanediol | C6H12O2 | 116.16 | 97-101 °C (lit.) | slightly soluble |
| 10 | 1792-88-7 | 3H-1,5-Benzodiazepine,2,4-dimethyl-, hydrochloride (1:1) | C11H13ClN2 | 208.68732 | | |
| 11 | 1792-91-2 | 3H-1,5-Benzodiazepine, 2,4-dimethyl-7-nitro-, hydrochloride (1:1) | C11H11N3O2.ClH | | | |
| 12 | 17920-15-9 | Dimethyl-(p-Tolyl)Silanol | C9H14OSi | 166.29236 | | |
| 13 | 17920-23-9 | 2-(Propargyl)malonic acid diethyl ester | C10H14O4 | 198.22 | 178℃ | |
| 14 | 17920-24-0 | p-Isopropenylphenyltrimethylsilane | | | | |
| 15 | 17920-35-3 | 2-Amino-6-methoxypyridine | C6H8N2O | 124.14 | | Slightly soluble in water. |
| 16 | 17920-37-5 | 6-AMino-1-Methylpyridin-2(1H)-one | C6H8N2O | 124.14052 | | |
| 17 | 17920-83-1 | 4-Pentenoicacid,5-phenyl-,(E)- | C11H12O2 | 176.21 | 87-88℃ | |
| 18 | 17920-85-3 | [4-(2-FURYL)PHENYL]METHANOL | C11H10O2 | 174.2 | 85-86.5 | |
| 19 | 17920-86-4 | Di-furan-2-yl-methanone | C9H6O3 | 162.14214 | | |
| 20 | 17920-88-6 | 2,2-Di(2-Furyl)Propane | C11H12O2 | 176.21 | -12 °C | |
| 21 | 17920-89-7 | Furan, 2,5-bis[1-(2-furanyl)-1-methylethyl]- | C18H20O3 | 284.3496 | | |
| 22 | 17921-59-4 | 3β-Acetoxy-17,17-(ethylenedioxy)androst-5-ene | C23H34O4 | 374.51366 | | |
| 23 | 17921-61-8 | (3S,10R,13S,14S,16R)-16-BROMO-10,13-DIMETHYL-1,2,3,4,7,8,9,10,11,12,13,14,15,16-TETRADECAHYDROSPIRO[CYCLOPENTA[A]PHENANTHRENE-17,2'-[1,3]DIOXOLAN]-3-OL | C21H31BrO3 | 411.37304 | | |
| 24 | 17921-62-9 | (3S,10R,13S,14S)-10,13-DIMETHYL-1,2,3,4,7,8,9,10,11,12,13,14-DODECAHYDROSPIRO[CYCLOPENTA[A]PHENANTHRENE-17,2'-[1,3]DIOXOLAN]-3-OL | C21H30O3 | 330.46 | | |
| 25 | 17921-63-0 | 5,15-ANDROSTDIENE-3-HYDROXY-17-ONE | C19H26O2 | 286.41 | | |
| 26 | 17921-64-1 | 3β-Hydroxy-androsta-5,15-dien-17-one Acetate | C21H28O3 | 328.45 | 179-181 °C(Solv: hexane (110-54-3)) | |
| 27 | 17921-68-5 | 4-Trimethylsilylbenzonitrile | C10H13NSi | 175.30242 | | |
| 28 | 17921-74-3 | Silane, dichloro(1,1-dimethylethoxy)phenyl- | C10H14Cl2OSi | 249.20906 | | |
| 29 | 17921-76-5 | Arsenic acid tris(trimethylsilyl) ester | | | | |
| 30 | 17921-92-5 | Silanamine, 1,1,1-trimethyl-N-(tributylphosphoranylidene)- | C15H36NPSi | 289.51 | | |
| 31 | 1792108-86-1 | cis-Hydroxy Praziquantel-d5 | C19H19D5N2O3 | 333.44 | | |
| 32 | 1792173-34-2 | 10-(4-(4-(9H -carbazol-9-yl)phenylsulfonyl)phenyl)-9,9-dimethyl- 9,10-dihydroacridine | C39H30N2O2S | 590.73 | | |
| 33 | 1792180-79-0 | 1-((2R,5S)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one | C15H19N5O | 285.34 | | |
| 34 | 1792180-81-4 | 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one | C15H19N5O | 285.34 | | |
| 35 | 1792180-87-0 | Ritlecitinib Impurity 15 | | | | |
| 36 | 1792180-91-6 | Ritlecitinib Impurity 14 | | | | |
| 37 | 1792180-97-2 | Ritlecitinib Impurity 23 | C18H25N5O2 | 343.42 | | |
| 38 | 1792181-05-5 | Ritlecitinib Impurity 34 | C16H19N5O | 297.36 | | |
| 39 | 1792181-07-7 | Ritlecitinib Impurity 21 | | | | |
| 40 | 1792181-33-9 | Vunakizumab | | | | |
| 41 | 1792181-39-5 | Ritlecitinib Impurity 11 | C15H19N5O2 | 301.34 | | |
| 42 | 1792181-65-7 | Ritlecitinib Impurity 33 | C16H19N5O | 297.36 | | |
| 43 | 1792181-97-5 | 1-((2S,5S)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one | C15H19N5O | 285.34 | | |
| 44 | 1792181-98-6 | 1-((2R,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one | C15H19N5O | 285.34 | | |
| 45 | 1792181-99-7 | 2-Propen-1-one, 1-[(2R,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-,rel- | C15H19N5O | 285.34 | | |
| 46 | 1792182-01-4 | Ritlecitinib Impurity 10 | C15H19N5O2 | 301.34 | | |
| 47 | 1792182-10-5 | 2-Propen-1-one, 1-[(2R,5S)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-,rel- | C15H19N5O | 285.34 | | |
| 48 | 1792182-41-2 | Ritlecitinib Impurity 19 | C16H18N6O | 310.35 | | |
| 49 | 1792182-42-3 | Ritlecitinib Impurity 24 | | | | |
| 50 | 1792184-36-1 | rel-benzyl (2R,5R)-5-((tert-butoxycarbonyl)amino)-2-methylpiperidine-1-carboxylate | C19H28N2O4 | 348.44 | | |
| 51 | 1792184-37-2 | N-((3R,6S)-6-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C12H17N5 | 231.3 | | |
| 52 | 1792184-40-7 | 1-Piperidinecarboxylic acid, 3-hydroxy-5-[[7-(triphenylmethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-, 1,1-dimethylethyl ester, (3R,5R)- | C35H37N5O3 | 575.7 | | |
| 53 | 1792184-41-8 | (R)-tert-butyl 3-oxo-5-((7-trityl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidine-1-carboxylate | | | | |
| 54 | 1792184-48-5 | benzyl 5-((tert-butoxycarbonyl)amino)-2-(hydroxymethyl)piperidine-1-carboxylate | C19H28N2O5 | 364.45 | | |
| 55 | 1792184-58-7 | (Cis)-benzyl hexahydro-lH-pyrrolo[2, 3-c]pyridine-6(2H)-carboxylate | C15H20N2O2 | 260.34 | | |
| 56 | 1792184-76-9 | benzyl (2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidine-1-carboxylate | C20H22ClN5O2 | 399.87 | | |
| 57 | 1792185-02-4 | (3S,5S)-5-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-3-piperidinol | C11H25NO2Si | 231.41 | | |
| 58 | 1792185-03-5 | 1-Piperidinecarboxylic acid, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5-hydroxy-, 1,1-dimethylethyl ester, (3S,5S)- | C16H33NO4Si | 331.52 | | |
| 59 | 1792186-31-2 | 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-[(3R,6R)-6-methyl-3-piperidinyl]-, rel- | C12H17N5 | 231.3 | | |
| 60 | 1792186-85-6 | 1H-Imidazo[4,5-c]pyridin-7-amine, N-(diphenylmethylene)-1-methyl- | C20H16N4 | 312.37 | | |
| 61 | 1792187-13-3 | 5H-Pyrrolo[2,3-b]pyrazine, 2-(1-piperazinyl)- | C10H13N5 | 203.24 | | |
| 62 | 1792190-52-3 | 4-Chloro-7-trityl-7h-pyrrolo[2,3-d]pyrimidine | C25H18ClN3 | 395.88 | | |
| 63 | 1792190-57-8 | 7H-Pyrrolo[2,3-d]pyrimidine, 4-chloro-5-(2-methoxyethyl)- | C9H10ClN3O | 211.65 | | |
| 64 | 1792190-59-0 | benzyl (3S,4R)-3-amino-4-fluoropiperidine-1-carboxylate | C13H17FN2O2 | 252.2846832 | | |
| 65 | 1792190-69-2 | Trans-Tert-Butylhexahydro-2H-Pyrido[4,3-B][1,4]Oxazine-6(7H)-Carboxylate | C12H22N2O3 | 242.31 | | |
| 66 | 1792190-70-5 | tert-butyl cis-3-amino-4-methylpiperidine-1-carboxylate | C11H22N2O2 | 214.3 | | |
| 67 | 1792190-72-7 | tert-butyl (2S,5R)-5-amino-2-methylpiperidine-1-carboxylate | C11H22N2O2 | 214.30458 | | |
| 68 | 1792190-80-7 | (1R,3S)-3-fluorocyclopentan-1-aMine | C5H10FN | 103.1380032 | | |
| 69 | 1792191-32-2 | O-(N-Butylfluorescein)-O-{3-[6-O-(D,L-1-ethoxyethyl)-1,2:4,5-bis-O-(1-methylethylidene)-D,L-myo-inos | C40H46LiO14P | 788.7 | | |
| 70 | 17922-14-4 | Silane, (4-ethenylphenyl)dimethylphenyl- | C16H18Si | 238.39962 | | |
| 71 | 17922-21-3 | Silane, (bromodiphenylmethyl)trimethyl- (6CI,8CI,9CI) | C16H19BrSi | 319.31 | | |
| 72 | 17922-24-6 | tert-butoxy-diphenylchlorosilane | C16H19ClOSi | 290.86 | | |
| 73 | 17922-30-4 | Benzamide, N-phenyl-2-(trimethylsilyl)- | C16H19NOSi | 269.41366 | | |
| 74 | 17922-31-5 | Methanone, diphenyl-, O-(trimethylsilyl)oxime | C16H19NOSi | 269.41 | | |
| 75 | 17922-43-9 | Silane, methyldiphenyl-2-propenyl- | C16H18Si | 238.4 | | |
| 76 | 17922-48-4 | Disiloxane, 1,3-dimethyl-1,1,3,3-tetrapropyl- | C14H34OSi2 | 274.59 | | |
| 77 | 17922-62-2 | Butyric acid, 2-(2-pyridylamino)-, 1-oxide, DL- (8CI) | C9H11N2O3 | 195.19524 | | |
| 78 | 17922-63-3 | Butyric acid, 3-(2-pyridylamino)-, 1-oxide, DL- (8CI) | C9H11N2O3 | 195.19524 | | |
| 79 | 17922-79-1 | (S)-Benzyl (1-(cyclohexylamino)-3-methyl-1-oxobutan-2-yl)carbamate | C19H28N2O3 | 332.44 | | |
| 80 | 17922-87-1 | H-GLY-ALA-PHE-OH | C14H19N3O4 | 293.32 | | |
| 81 | 17922-88-2 | Z-DL-Phg-NHCyh | C22H26N2O3 | 366.46 | | |
| 82 | 17922-96-2 | 4-cyano-N-phenylbenzamide | C14H10N2O | 222.24 | | |
| 83 | 17922-99-5 | 4-cyano-N-(phenylmethyl)- Benzamide | C15H12N2O | 236.27 | | |
| 84 | 1792203-15-6 | 3-amino-6-chloro-5-((4-chlorobenzyl)amino)pyrazine-2-carboxylic acid | C12H10Cl2N4O2 | 313.14 | | |
| 85 | 1792203-37-2 | Carbamic acid, N-(6-aminohexyl)-N-methyl-, 1,1-dimethylethyl ester | C12H26N2O2 | 230.35 | | |
| 86 | 1792207-06-7 | Quinazoline, 4-chloro-2-[3-(1-naphthalenyl)phenyl]- | C24H15ClN2 | 366.84 | | |
| 87 | 1792207-14-7 | Quinazoline, 4-chloro-2-(2-naphthalenyl)- | C18H11ClN2 | 290.75 | | |
| 88 | 1792211-00-7 | Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'-(hydrogen butanedioate), compd. with N,N-diethylethanamine (1:1) | C41H51N3O11 | 761.87 | | |
| 89 | 1792211-87-0 | 9H-Carbazole,9-butyl-2,7-bis(1H-1,2,4-triazol-1-yl)- | C20H19N7 | 357.41 | | |
| 90 | 1792218-53-1 | 1,3,2-Dioxaborolane, 2-(9,9-dimethyl-9H-fluoren-1-yl)-4,4,5,5-tetramethyl- | C21H25BO2 | 320.23 | | |
| 91 | 1792219-00-1 | 9H-Fluoren-2-amine, N-[1,1''-biphenyl]-4-yl-N-[2-(9,9-diphenyl-9H-fluoren-4-yl)phenyl]-9,9-dimethyl- | C58H43N | 753.97 | | |
| 92 | 1792224-09-9 | 2-Amino-6,6-dimethyl-5,6,7,8-tetrahydroquinazolin-5-one | C10H13N3O | 191.23 | | |
| 93 | 1792224-20-4 | 1-Bromo-2-[(4-methoxyphenyl)methoxy]-3-methylbenzene | C15H15BrO2 | 307.19 | | |
| 94 | 1792228-89-7 | Toludesvenlafaxine Impurity | C24H29NO2 | 363.49 | | |
| 95 | 1792228-90-0 | Benzoic acid, 4-methyl-, 4-[1-(1-cyclohexen-1-yl)-2-(dimethylamino)ethyl]phenyl ester, hydrochloride (1:1) | C24H29NO2.ClH | 399.95 | | |
| 96 | 1792234-08-2 | sodium 3-oxo-3H-benzo[d]isothiazol-2-ide 1,1-dioxide | C7H4NNaO3S | 205.16633 | | |
| 97 | 1792235-57-4 | 3-(trifluoromethyl)pyridazine-4-carboxylic acid | C6H3F3N2O2 | 192.1 | | |
| 98 | 179231-43-7 | 1H-Imidazolium, 1,3-dipropyl-, bromide (1:1) | | | 67.2 °C | |
| 99 | 179232-29-2 | Methyl 4-bromo-2-fluorobenzoate | C8H6BrFO2 | 233.03 | 58-60℃ | |
| 100 | 179232-31-6 | Benzoyl chloride, 4-ethynyl-2-fluoro- (9CI) | C9H4ClFO | 182.5788632 | | |
| 101 | 179233-83-1 | R,7R,7aR,8aS)- | C29H42O7 | 502.63958 | | |
| 102 | 179234-02-7 | 3-Benzofuranmethanol, 7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-5-[(1E)-3-hydroxy-1-propen-1-yl]- | C19H18O6 | 342.34 | | |
| 103 | 179234-89-0 | 3-(1-benzylpiperidin-4-yl)-1H-indole | C20H22N2 | 290.4 | | |
| 104 | 179235-07-5 | (8aS)-tetrahydro-1H-Pyrrolo[2,1-c][1,4]oxazin-4(3H)-one | C7H11NO2 | 141.16774 | | |
| 105 | 179236-05-6 | (2S,3R)-1-(tert-butoxycarbonyl)-3-ethylpyrrolidine-2-carboxylic acid | | | | |
| 106 | 179236-11-4 | T176-4 | C25H32O4Si | 424.61 | | |
| 107 | 179236-77-2 | (2R,4R)-4-Methyl-2-piperidinecarboxylicethylester | C9H17NO2 | 171.24 | | |
| 108 | 179236-78-3 | 3-Azabicyclo[3.1.0]hexane-3,6-dicarboxylic acid 3-(tert-butyl) 6-ethyl ester | C13H21NO4 | 255.31 | | |
| 109 | 179236-79-4 | Ethyl 3-azabicyclo[3.1.0]hexane-6-carboxylate | C8H13NO2 | 155.194 | | |
| 110 | 179237-49-1 | CGP52421 | C35H30N4O5 | 586.65 | | |
| 111 | 179237-91-3 | tube1124 | | | | |
| 112 | 179237-92-4 | (S)-1-(2,4-dichlorophenyl)ethanol | C8H8Cl2O | 191.05452 | | |
| 113 | 179238-46-1 | 1-((3S,4S)-4-amino-3-hydroxy-2,2-dimethylchroman-6-yl)ethan-1-one | C13H17NO3 | 235.28 | | |
| 114 | 179239-32-8 | Cyclopentanecarboxylic acid, 1-[3-([1,1'-biphenyl]-4-ylmethyl)-3,4-dihydro-4-hydroxy-2H-1-benzopyran-7-yl]-, ethyl ester, cis- (9CI) | C30H32O4 | 456.57 | | |
| 115 | 179239-79-3 | (3aR,5S,6S,6aS)-2-amino-5-(hydroxymethyl)-3a,5,6,6a-tetrahydrofuro[2,3-d]oxazol-6-ol | C6H10N2O4 | 174.15 | | |
| 116 | 179239-81-7 | 2(1H)-Pyrimidinone, 4-amino-1-α-L-ribofuranosyl- | C9H13N3O5 | 243.22 | | |
| 117 | 179239-88-4 | 2(1H)-Pyrimidinone, 4-amino-1-(tetrahydro-3,4-dihydroxy-2-furanyl)-, [2S-(2alpha,3ba,4ba)]- (9CI) | C8H11N3O4 | | | |
| 118 | 17924-92-4 | zearalenone | C18H22O5 | 318.36 | 164-165°C | |
| 119 | 179240-09-6 | 2H-Benz[e]isoindole-2-ethanamine, 1,3,3a,4,5,9b-hexahydro-6-methoxy-, (3aR,9bR)- | C15H22N2O | 246.35 | | |
| 120 | 179240-10-9 | rel-(3aR,9bR)-6-Methoxy-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]isoindole | C13H17NO | 203.29 | | |
| 121 | 179240-13-2 | Benzenamine, 4,4-methylenebis-, reaction products with (2-methylphenoxy)methyloxirane | | | | |
| 122 | 179240-14-3 | Iron magnesium manganese strontium oxide (Fe2.01-2.11Mg0.66-0.76Mn0.17-0.21Sr0-0.02O4) | FeH6MgMnOSr | 244.76 | | |
| 123 | 179240-22-3 | Variolink | | | | |
| 124 | 179241-43-1 | 4-[[(2,3-Dihydro-1,1,3,3-tetramethyl-2-oxo-1H-inden-5-yl)carbonyl]amino]benzoicacid | C21H21NO4 | 351.39574 | | |
| 125 | 179241-74-8 | glucuronyl-galactosyl-proteoglycan 4-α-N-acetylglucosaminyltransferase | | | | |
| 126 | 179241-78-2 | FLICE | | | | |
| 127 | 179244-72-5 | 3-(2-PHENYLETHYNYL)BENZOIC ACID METHYL ESTER | C17H14O2 | 250.29 | | |
| 128 | 179245-19-3 | N-(1-butoxy-2,3,5,6-tetrachloro-4-oxo-2,5-cyclohexadien-1-yl)-4-methylbenzenesulfonamide | C17H17Cl4NO4S | 473.19818 | | |
| 129 | 179245-36-4 | Cyclohexane, 1-bromo-4-butyl- | C10H19Br | 219.16186 | | |
| 130 | 179246-08-3 | GW 284543 hydrochloride | C23H21ClN2O3 | 408.88 | | |
| 131 | 179246-09-4 | 4(3H)-Quinazolinone, 6-(trifluoromethoxy)- | C9H5F3N2O2 | 230 | | |
| 132 | 179246-11-8 | 6-ACETOXY-4-CHLOROQUINAZOLINE | C10H7ClN2O2 | 222.63 | | |
| 133 | 179246-12-9 | 7-ACETOXY-4-CHLOROQUINAZOLINE | C10H7ClN2O2 | 222.63 | | |
| 134 | 179246-13-0 | 4-hydroxyquinazolin-7-yl acetate | C10H8N2O3 | 204.18 | | |
| 135 | 179246-14-1 | 4-CHLORO-5-METHOXYQUINAZOLINE | C9H7ClN2O | 194.61 | | |
| 136 | 179246-15-2 | 4(1H)-Quinazolinone, 6,7-diethoxy- (9CI) | C12H14N2O3 | 234.25 | 248-251.5℃ | |
| 137 | 179246-24-3 | 4-(BENZYLOXY)-2-(TRIFLUOROMETHYL)ANILINE | C14H12F3NO | 267.25 | | |
| 138 | 179246-28-7 | CHEMBRDG-BB 4010406 | C11H11NOS | 205.28 | | |
| 139 | 179246-32-3 | 4-(FURAN-2-YLMETHOXY)-PHENYLAMINE | C11H11NO2 | 189.22 | | |
| 140 | 179246-35-6 | 2-(4-NITRO-PHENOXYMETHYL)-[1,3]DIOXOLANE | C10H11NO5 | 225.2 | | |
| 141 | 179246-45-8 | Benzenamine, 3-chloro-4-[(2-fluorophenyl)methoxy]- | C13H11ClFNO | 251.68 | | |
| 142 | 179247-42-8 | N-(4-((6,7-DIMETHOXY-4-QUINAZOLINYL)AMIN | C23H20N4O3.ClH | 436.897 | | |
| 143 | 179248-59-0 | Src Inhibitor 1 | C22H19N3O3 | 373.4 | | |
| 144 | 179248-61-4 | EGFR/ErbB-2 Inhibitor | C23H21N3O3 | 387.43 | | |
| 145 | 179248-67-0 | 6-NITRO-N-(4-PHENOXYPHENYL)QUINAZOLIN-4-AMINE | C20H14N4O3 | 358.35 | | |
| 146 | 179248-86-3 | Benzonitrile, 4-[(1S)-1-hydroxy-2-propynyl]- | C10H7NO | 157.16868 | | |
| 147 | 179249-15-1 | Benzenemethanol, alpha-ethynyl-4-fluoro-, (R)- (9CI) | C9H7FO | 150.1496832 | | |
| 148 | 179249-16-2 | Benzenemethanol, alpha-ethynyl-4-fluoro-, (alphaS)- (9CI) | C9H7FO | 150.15 | | |
| 149 | 179249-17-3 | Benzenemethanol, alpha-ethynyl-3-fluoro-, (R)- (9CI) | C9H7FO | 150.1496832 | | |
| 150 | 179249-18-4 | Benzenemethanol, alpha-ethynyl-3-fluoro-, (S)- (9CI) | C9H7FO | 150.15 | | |
| 151 | 179249-41-3 | 1,4-Cyclohexanediol,2-(1-methylethyl)-,(1alpha,2alpha,4alpha)-(9CI) | C9H18O2 | | | |
| 152 | 179249-42-4 | 2,3-Dioxabicyclo[2.2.2]octane,5-(1-methylethyl)-,(1alpha,4alpha,5bta)-(9CI) | C9H16O2 | 156.22214 | | |
| 153 | 179249-43-5 | Hydroperoxide, 3-(1-methylethyl)-2-cyclohexen-1-yl (9CI) | C9H16O2 | 156.22214 | | |
| 154 | 17925-16-5 | 5-(Morpholinomethyl)-3-[(5-nitro-2-thenylidene)amino]-2-oxazolidinone | | | | |
| 155 | 17925-19-8 | 2-amino-5,5-diphenyl-1,3-oxazol-4-one | C15H12N2O2 | 252.27 | | |
| 156 | 17925-90-5 | 1H-Imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazen-1-yl)-, hydrochloride (1:1) | C6H11ClN6O | 218.65 | | |
| 157 | 17925-93-8 | Benzoic acid, 4-[2-(diethylamino)ethoxy]-3-[[[4-(ethoxycarbonyl)phenyl]amino]carbonyl]-, methyl ester | C24H30N2O6 | 442.5 | | |
| 158 | 17925-97-2 | Benzene, 1-chloro-4-[2,2,2-trichloro-1-(4-Methylphenyl)ethyl]- | C15H12Cl4 | 334.07 | | |
| 159 | 179250-25-0 | 1-Boc-4-(2-cyanophenyl)piperazine | C16H21N3O2 | 287.357 | | |
| 160 | 179250-28-3 | TERT-BUTYL 4-[2-(HYDROXYMETHYL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE | C16H24N2O3 | 292.38 | 67 °C | |
| 161 | 179250-64-7 | 2-Pyrimidinamine, 4-chloro-6-(1-piperazinyl)- | C8H12ClN5 | 213.67 | | |
| 162 | 179251-28-6 | Benzene, 1-bromo-4-(cyclopropylmethyl)- | C10H11Br | 211.1 | | |
| 163 | 179251-57-1 | 2-broMo-4-(Methyloxy)benzenesulfonyl chloride | C7H6BrClO3S | 285.54 | | |
| 164 | 179251-60-6 | BOC-D-DAP(ALLOC)-OH | C12H20N2O6 | 288.3 | | |
| 165 | 179252-79-0 | (2-Fluoro-4-methoxycarbonyl-benzyl)-triphenylphosphonium bromide | C27H23BrFO2P | 509.36 | | |
| 166 | 179254-04-7 | 2-(2-(benzyloxy)-4-bromophenyl)-1,3-dioxolane | C16H15BrO3 | 335.2 | | |
| 167 | 179257-03-5 | methyl 3-(5-bromo-2-hydroxyphenyl)propanoate | C10H11BrO3 | 259.1 | | |
| 168 | 179257-30-8 | 2-Benzyloxy-3-pyridinecarbaldehyde | C13H11NO2 | 213.23 | | |
| 169 | 179258-52-7 | 4-THIAZOLEACETIC ACID, 2-AMINO-ALPHA-[[2-(1,1-DIMETHYLETHOXY)-1,1-DIMETHYL-2-OXOETHOXY]IMINO]-, ANHYDRIDE WITH DIETHYL HYDROGEN PHOSPHATE, (Z)- | C17H28N3O8PS | 465.46 | | |
| 170 | 179258-53-8 | 4-THIAZOLEACETIC ACID, 2-AMINO-ALPHA-(METHOXYIMINO)-, ANHYDRIDE WITH DIETHYL HYDROGEN PHOSPHATE, (Z)- | C10H16N3O6PS | 337.29 | | |
| 171 | 179258-59-4 | Benzamide, N-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]-4-nitro- | C20H25N3O5 | 387.43 | | |
| 172 | 179258-62-9 | Benzamide, N-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]-4-nitro-, hydrochloride (1:1) | C20H26ClN3O5 | 423.89 | | |
| 173 | 179258-63-0 | 179258-63-0 | C10H11ClN2O3 | 242.66 | | |
| 174 | 179259-37-1 | 2-Cyclohexen-1-one, 2,6,6-trimethyl-5-(1-methylethenyl)-, (5S)- | C12H18O | 178.27 | | |
| 175 | 17926-15-7 | hydrogen tetrakis(4,4,4-trifluoro-1-phenylbutane-1,3-dionato-O,O')europate(1-), compound with dimethylamine (1:1) | C42H36EuF12NO8+ | 1062.6819784 | | |
| 176 | 17926-77-1 | SCANDIUM OXALATE | C6H20O22Sc2 | 534.12 | >500°C | |
| 177 | 179260-78-7 | Trifluoromethanesulfonic Acid 4-Methyl-2-Pyridyl Ester | C7H6F3NO3S | 241.19 | | |
| 178 | 179260-95-8 | 5-bromo-2-phenylpyrimidine-4-carboxylic acid | C11H7BrN2O2 | 279.08948 | | |
| 179 | 179261-24-6 | Isothiazolo[4,5-c]pyridin-3(2H)-one, 4,5,6,7-tetrahydro- | C6H8N2OS | 156.21 | | |
| 180 | 179261-28-0 | Potassium, [diphenyl(trimethylsilyl)methyl]- | C16H19KSi | 278.51 | | |
| 181 | 179262-62-5 | 1,4-Benzodioxin-5-carboxylicacid,6-amino-2,3-dihydro-,methylester(9CI) | C10H11NO4 | | | |
| 182 | 179264-44-9 | 4,4''-(2,5-DIBUTOXY-1,4-PHENYLENE)BIS[2-METHYL-3-BUTYN-2-OL] | C24H34O4 | | | |
| 183 | 179264-45-0 | 4,4''[2,5-BIS(DECYLOXY)-1,4-PHENYLENE]BIS[2-METHYL-3-BUTYN-2-OL] | C30H52O4 | | | |
| 184 | 179264-81-4 | TRITRPTICIN | C96H132N28O14 | 1902.25 | | |
| 185 | 179266-64-9 | Acetamide, N-(2,3-dihydro-1H-inden-2-yl)-N-methyl- | C12H15NO | 189.25 | | |
| 186 | 179268-21-4 | 4H-1,2,3-Triazolo[4,5-d]pyrimidine (9CI) | C4H3N5 | 121.10012 | | |
| 187 | 179268-22-5 | 6H-1,2,3-Triazolo[4,5-d]pyrimidine (9CI) | C4H3N5 | 121.1 | | |
| 188 | 179268-62-3 | ISOOCTAHEXACONTA NE | | | | |
| 189 | 179268-63-4 | ISOHEXAPENTACONT AHECTANE | C156H314 | 2190.16236 | | |
| 190 | 17927-44-5 | oxomolybdenum pentahydrochloride | Cl5H5MoO | 294.2441 | | |
| 191 | 17927-57-0 | Diborane(6), chloro- | B2ClH5 | 62.11 | | |
| 192 | 17927-65-0 | Dialuminum trisulfate hydrate | Al2H2O13S3 | 360.17 | 86.5℃ | |
| 193 | 17927-68-3 | Triboron trioxide tetrahydroxide ion(-1) | B3H4O7-1 | | | |
| 194 | 17927-72-9 | bis(pentane-2,4-dionato-O,O')bis(propan-2-olato)titanium | C16H28O6Ti | 364.26 | | Hydrolyze with water. |
| 195 | 17928-09-5 | 5-(2-Aminoethyl)-4-methylthiazole monohydrochloride | C6H10N2S.HCl | 178.68 | | |
| 196 | 17928-10-8 | 5-Thiazoleethanamine, N,N-diethyl-4-methyl-, hydrochloride (1:2) | C10H19ClN2S | 234.79 | | |
| 197 | 17928-11-9 | 1,3-Propanediamine, N1,N1-diethyl-N3-[2-(4-methyl-5-thiazolyl)ethyl]-, hydrochloride (1:3) | C13H26ClN3S | 291.88 | | |
| 198 | 17928-12-0 | Piperazine, 1-methyl-4-[2-(4-methyl-5-thiazolyl)ethyl]-, hydrochloride (1:3) | C11H20ClN3S | 261.81 | | |
| 199 | 17928-13-1 | 1,1,3,3,5,5-HEXAMETHYLDIETHOXYTRISILOXANE | C10H28O4Si3 | 296.58 | -126°C | |
| 200 | 17928-28-8 | Methyltris(trimethylsiloxy)silane | C10H30O3Si4 | 310.69 | -76°C | |
| 201 | 17928-31-3 | 1,7-DIMETHOXY OCTAMETHYLTETRASILOXANE | C10H30O5Si4 | 342.68 | | |
| 202 | 17928-61-9 | (1aS,1bR,2aR,6R,6aR,9aS,10aS)-1a,1b,2a,6a,7,9a,10,10a-Octahydro-10a-methyl-7-methylene-4H-6,3-methenofuro[3,2-c]bisoxireno[f,h]oxacycloundecin-4,8(6H)-dione | C15H14O6 | 290.27 | | |
| 203 | 17928-63-1 | Sugetriol 6,9-diacetate | C19H28O5 | 336.423 | | |
| 204 | 17928-77-7 | 2-Cyclohexen-1-one, 4-(hydroxymethyl)-3-[(1E,3E)-5-hydroxy-3-methyl-1,3-pentadien-1-yl]-2,4-dimethyl-, (4S)- | C15H22O3 | 250.33 | | |
| 205 | 17928-78-8 | 1,6,7,7a-Tetrahydro-4,7a-dimethyl-3-(2-methyl-1,3-butadienyl)-5(3H)-isobenzofuranone | | | | |
| 206 | 1792885-92-7 | 3-Chloro-2-iodo-4- (trifluoromethoxy)aniline | C7H4ClF3INO | 337.47 | | |
| 207 | 17929-01-0 | N-Methyl-N,N,N-triallylammonium methosulfate | C10H18N.CH3O4S | 263.36 | | |
| 208 | 17929-31-6 | 2(3H)-Benzoxazolone, 5-chloro-3-(1-pyrrolidinylmethyl)- | C12H13ClN2O2 | 252.7 | | |
| 209 | 17929-34-9 | 5-Chloro-3-(hydroxymethyl)benzoxazol-2(3H)-one | C8H6ClNO3 | 199.59 | | |
| 210 | 17929-68-9 | indole-3-acetyl-epsilon-lysine | C16H21N3O3 | 303.36 | | |
| 211 | 17929-90-7 | dl-A-amino-epsilon-caprolactam | C6H12N2O | 128.17 | 77°C | |
| 212 | 1792939-17-3 | Benzenamine, 3-ethynyl-2,4-difluoro- | C8H5F2N | 153.13 | | |
| 213 | 1792968-00-3 | EGFR ligand-14 | | | | |
| 214 | 1792976-25-0 | Ethanone, 1-[1-(cyclopropylmethyl)-1H-pyrazol-3-yl]- | C9H12N2O | 164.2 | | |
| 215 | 1792981-74-8 | Diethyl N-[(1S,2S)-2-aminocyclohexyl]phosphoramidate | | | | |
| 216 | 1792981-76-0 | Diethyl N-[(1S,2S)-2-[(1-naphthalenylmethyl)amino]cyclohexyl]phosphoramidate | C21H31N2O3P | 390.46 | | |
| 217 | 1792981-78-2 | diisopropyl((1S,2S)-2-aminocyclohexyl)phosphoramidate | C12H27N2O3P | 278.33 | | |
| 218 | 1792981-84-0 | Diphenyl N-[(1S,2S)-2-aminocyclohexyl]phosphoramidate | | | | |
| 219 | 1792981-93-1 | Diethyl ((1S,2S)-2-((4-methoxybenzyl)amino)cyclohexyl)phosphoramidate | C18H31N2O4P | 370.43 | | |
| 220 | 1792982-55-8 | Porgaviximab | | | | |
| 221 | 1792982-56-9 | Larcaviximab | | | | |
| 222 | 1792982-57-0 | Cosfroviximab | | | | |
| 223 | 1792986-63-0 | diethyl((1R,2R)-2-amino-1,2-diphenylethyl)phosphoramidate | C18H25N2O3P | 348.38 | | |
| 224 | 1792991-66-2 | Azacitidine Impurity 44 | C29H25N5O8 | 571.54 | | |
| 225 | 1792993-81-7 | Benzoxazole, 4-bromo-2-phenyl- | C13H8BrNO | 274.11 | | |
| 226 | 1792993-82-8 | 2-Phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole | C19H20BNO3 | 321.18 | | |
| 227 | 1792993-84-0 | Daridorexant hydrochloride | C23H24Cl2N6O2 | 487.39 | | |
| 228 | 1792994-02-5 | 7-Bromo-2-phenyl-5H-oxazolo[5,4-b]carbazole | C19H11BrN2O | 363.21 | | |
| 229 | 1792996-60-1 | Boronic acid, B-[2-(methoxymethyl)-4-pyridinyl]- | C7H10BNO3 | 166.97 | | |
| 230 | 1792996-62-3 | 6-fluoro-N,N-diMethyl-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-aMine | C13H20BFN2O2 | 266.1195032 | | |
| 231 | 1792999-26-8 | NCB-0846 | C21H21N5O2 | 375.42 | | |